SCHEMBL6638482

SCHEMBL6638482

Cc1c(F)cccc1C1CCNCC1

nearest known ligand 0.69

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
HTR2C P28335 4/20 0.69
HTR6 P50406 8/20 0.58
HTR1A P08908 8/20 0.55
SLC6A2 P23975 8/20 0.55
SLC6A4 P31645 8/20 0.55
SLC6A3 Q01959 4/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6075674 0.98 HTR2C (0.70) HTR2CHTR6HTR1ASLC6A2SLC6A4
SCHEMBL19633961 0.87 HTR2C (0.48) HTR2CHTR6HTR1ASLC6A2SLC6A4
SCHEMBL5584737 0.81 HTR2C (1.00) HTR2CHTR6HTR1ASLC6A2SLC6A4
SCHEMBL3765929 0.81 HTR1A (0.58) HTR2CHTR6HTR1ASLC6A2SLC6A4
SCHEMBL30368779 0.81 HTR1A (0.61) HTR2CHTR1ASLC6A2SLC6A4SLC6A3
SCHEMBL233327 0.81 HTR1A (0.61) HTR2CHTR1ASLC6A2SLC6A4SLC6A3
Hydrochloric Acid SCHEMBL21855666 0.80 HTR2C (1.00) HTR2CHTR6HTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL31109384 0.80 HTR2C (1.00) HTR2CHTR6HTR1ASLC6A2SLC6A4
Hydrochloric Acid SCHEMBL4893603 0.80 HTR1A (0.56) HTR2CHTR6HTR1ASLC6A2SLC6A4
SCHEMBL741486 0.80 HTR2C (0.43) HTR2CHTR6HTR1ASLC6A2SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1432701-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT RECORDATI S.A. CHEMICAL and PHARMACEUTICAL COMPANY (CH) 2004-06-30 EP claimed
WO-2003031436-A1 HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF DISORDERS OF THE URINARY TRACT RECORDATI S.A. (CH) 2003-04-17 WO claimed
EP-2220083-B1 IMIDAZO[1,2-A]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS JANSSEN PHARMACEUTICALS INC (US) 2017-07-19 EP disclosed